FDA panel OKs Lilly using Cymbalta for pain - Topix
Links shared publicly online about this topic.
- 936total visits
FDA panel OKs Lilly using Cymbalta for pain - Topix
View full resource at topix.com
Tags: Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, FDA, Cymbalta
Most Recently Shared on August 19, 2010 at 10:29 pm By:
FDA panel OKs Lilly using Cymbalta for pain: A majority of federal health advisers say a best-selling antidepressa... http://bit.ly/9fsw4X
Cymbalta Nears Approval for Use on Chronic Pain - NYTimes.com
nytimes.com — “An advisory panel to the Food and Drug Administration voted 8-6 to expand approved uses of Cymbalta.” View full resource at nytimes.com
Most Recently Shared on August 20, 2010 at 11:02 pm By:
Eli Lilly closer to getting Cymbalta approved to help with chronic pain. FDA in favor with 8-6 vote. http://dld.bz/s9Ex
UPDATE 2-FDA panel backs wider use of Eli Lilly's Cymbalta | Reuters
reuters.com — “* Eli Lilly's Cymbalta OK'd for chronic pain -FDA panel * Panelists split over back pain, arthritis use * Drugmaker seeking FDA approval to promote new use * FDA deadline passed, decision could come” View full resource at reuters.com
Most Recently Shared on August 20, 2010 at 3:59 pm By:
Women In Pain Health Organization
FDA panel supports Cymbalta for back pain, but not osteoarthritis http://www.reuters.com/article/idUSN1925181020100819 http://fb.me/FZGJbQkQ
News: FDA panel backs wider use of Eli Lilly's Cymbalta in chronic pain http://bit.ly/beWoNf - #health
reuters.com — “News: FDA panel backs wider use of Eli Lilly's Cymbalta in chronic pain http://bit.ly/beWoNf - #health” View full resource at reuters.com
Most Recently Shared on August 20, 2010 at 12:45 am By:
Hisham Rana, MD Doctor and Physician
News: FDA panel backs wider use of Eli Lilly's Cymbalta in chronic pain http://bit.ly/beWoNf - #health
FDA Panel Supports Cymbalta for Chronic Pain
webmd.com — “An FDA advisory panel gave a closely divided vote of support to drugmaker Eli Lilly's application to increase the number of approved uses for one of its best-selling drugs, the antidepressant Cymbalta.” View full resource at webmd.com
Most Recently Shared on August 20, 2010 at 12:19 am By:
webMD: FDA Panel Supports Cymbalta for Chronic Pain http://bit.ly/9bfyNN Full http://bit.ly/cwUeLw
Lilly wins panel's backing to expand Cymbalta use | Indianapolis Business Journal | IBJ.com
ibj.com — “Eli Lilly and Co., the drugmaker whose top three products face generic competition within three years, won a U.S. panel’s backing to expand use of the antidepressant Cymbalta in chronic knee and back pain. Outside advisers to the Food and Drug Administration voted 8-6 Thursday in Bethesda, Md., in favor of a broader use of Cymbalta on the basis of studies in lower back pain and osteoarthritis of the knee. The FDA usually follows its panels’ recommendations, though it isn’t requ” View full resource at ibj.com
Most Recently Shared on August 19, 2010 at 11:10 pm By:
Lilly gains panel's backing to expand Cymbalta use: Outside advisers to the Food and Drug Administration voted 8-6... http://bit.ly/9wdbD0
F.D.A. Panel Approves Use of Antidepressant for Pain - QualityPoint Technologies
qualitypointtech.net — “An advisory committee votes to allow Eli Lilly to market Cymbalta for chronic pain, especially back ailments. (Source: NYT Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 9:30 pm By:
F.D.A. Panel Approves Use of Antidepressant for Pain: An advisory committee votes to allow Eli Lilly to market Cym... http://bit.ly/bMBGWP
F.D.A. Panel Approves Use of Antidepressant for Pain - Prescriptions Blog - NYTimes.com
prescriptions.blogs.nytimes.com — “An advisory committee votes to allow Eli Lilly to market Cymbalta for chronic pain, especially back ailments.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on August 19, 2010 at 8:08 pm By:
F.D.A. Panel Approves Use of Antidepressant for Pain: An advisory committee votes to allow Eli Lilly to market Cym... http://bit.ly/9CcLIO
FDA delays panel review of Cymbalta for chronic pain - Related Stories - AANP SmartBrief
smartbrief.com — “The FDA called off a panel review regarding the use of Eli Lilly and Co.'s antidepressant Cymbalta for chronic pain to give the agency more time to evaluate safety information on the indication. The company said it already submitted additional studies and continues "routine safety monitoring that --” View full resource at smartbrief.com
Most Recently Shared on January 6, 2010 at 6:51 pm By:
Women In Pain Health Organization
FDA delays panel review of Cymbalta for chronic pain http://sbne.ws/r/3BbF
Advertisement
